993 related articles for article (PubMed ID: 24907749)
21. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
[TBL] [Abstract][Full Text] [Related]
22. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
25. Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity.
Hong GB; Zhou JX; Yuan RX
Int J Nanomedicine; 2012; 7():2863-72. PubMed ID: 22745549
[TBL] [Abstract][Full Text] [Related]
26. Polymeric Reactor for the Synthesis of Superparamagnetic-Thermal Treatment of Breast Cancer.
Alhasan AH; Fardous RS; Alsudir SA; Majrashi MA; Alghamdi WM; Alsharaeh EH; Almalik AM
Mol Pharm; 2019 Aug; 16(8):3577-3587. PubMed ID: 31291120
[TBL] [Abstract][Full Text] [Related]
27. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
[TBL] [Abstract][Full Text] [Related]
28. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
Liu ZJ; Song XX; Tang Q
Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
[TBL] [Abstract][Full Text] [Related]
29. Folate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imaging.
Yoo MK; Park IK; Lim HT; Lee SJ; Jiang HL; Kim YK; Choi YJ; Cho MH; Cho CS
Acta Biomater; 2012 Aug; 8(8):3005-13. PubMed ID: 22543005
[TBL] [Abstract][Full Text] [Related]
30. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.
Madru R; Kjellman P; Olsson F; Wingårdh K; Ingvar C; Ståhlberg F; Olsrud J; Lätt J; Fredriksson S; Knutsson L; Strand SE
J Nucl Med; 2012 Mar; 53(3):459-63. PubMed ID: 22323777
[TBL] [Abstract][Full Text] [Related]
31. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
32. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K
Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995
[TBL] [Abstract][Full Text] [Related]
33. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
34. Uniform PEGylated PLGA Microcapsules with Embedded Fe3O4 Nanoparticles for US/MR Dual-Modality Imaging.
Xu S; Yang F; Zhou X; Zhuang Y; Liu B; Mu Y; Wang X; Shen H; Zhi G; Wu D
ACS Appl Mater Interfaces; 2015 Sep; 7(36):20460-8. PubMed ID: 26327472
[TBL] [Abstract][Full Text] [Related]
35. Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles.
Maurizi L; Papa AL; Dumont L; Bouyer F; Walker P; Vandroux D; Millot N
J Biomed Nanotechnol; 2015 Jan; 11(1):126-36. PubMed ID: 26301306
[TBL] [Abstract][Full Text] [Related]
36. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor.
Nosrati H; Salehiabar M; Fridoni M; Abdollahifar MA; Kheiri Manjili H; Davaran S; Danafar H
Sci Rep; 2019 May; 9(1):7173. PubMed ID: 31073222
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
Mol Imaging; 2015; 14():. PubMed ID: 26044549
[TBL] [Abstract][Full Text] [Related]
38. Fluorescent oligo(p-phenyleneethynylene) contained amphiphiles-encapsulated magnetic nanoparticles for targeted magnetic resonance and two-photon optical imaging in vitro and in vivo.
Yin C; Hong B; Gong Z; Zhao H; Hu W; Lu X; Li J; Li X; Yang Z; Fan Q; Yao Y; Huang W
Nanoscale; 2015 May; 7(19):8907-19. PubMed ID: 25916546
[TBL] [Abstract][Full Text] [Related]
39. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
[TBL] [Abstract][Full Text] [Related]
40. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
